Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MIRM

Mirum Pharmaceuticals Inc

May 29 • 04:00PM ET

101.50

+1.90 1.91 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN KRYS RYTM AXSM INCY MDGL PTGX VKTX KROS NBIX

| Held by: VTI XBI IWM VB VXF IBB VBK IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-13.60	Insider Own	18.68%	Shs Outstand	60.93M	Perf Week	0.82%
Market Cap	6.19B	Forward P/E	-	EPS next Y	-0.60	Insider Trans	-0.94%	Shs Float	49.59M	Perf Month	7.75%
Enterprise Value	6.13B	PEG	-	EPS next Q	-0.76	Inst Own	95.36%	Short Float	16.53%	Perf Quarter	9.98%
Income	-798.84M	P/S	10.87	EPS this Y	-3196.82%	Inst Trans	11.26%	Short Ratio	8.36	Perf Half Y	41.44%
Sales	569.61M	P/B	25.50	EPS next Y	96.13%	ROA	-101.04%	Short Interest	8.20M	Perf YTD	28.50%
Book/sh	3.98	P/C	16.02	EPS next 5Y	-	ROE	-335.82%	52W High	114.99 -11.73%	Perf Year	130.68%
Cash/sh	6.33	P/FCF	-	EPS past 3/5Y	51.26% 35.25%	ROIC	-141.66%	52W Low	43.30 134.41%	Perf 3Y	288.44%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	89.13% -	Gross Margin	81.32%	Volatility	4.24% 6.36%	Perf 5Y	513.66%
Dividend TTM	-	EV/Sales	10.76	EPS Y/Y TTM	-742.29%	Oper. Margin	-12.31%	ATR (14)	5.29	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.99	Sales Y/Y TTM	50.19%	Profit Margin	-140.24%	RSI (14)	52.68	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	2.09	EPS Q/Q	-4372.49%	SMA20	-0.92%	Beta	0.50	Target Price	144.15
Payout	-	Debt/Eq	1.34	Sales Q/Q	43.28%	SMA50	4.55%	Rel Volume	1.36	Prev Close	99.60
Employees	372	LT Debt/Eq	1.33	Earnings	May 06 AMC	SMA200	20.45%	Avg Volume	980.98K	Price	101.50
IPO	Jul 18, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3576.43% 7.89%	Trades		Volume	1,334,727	Change	1.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)